✦ LIBER ✦

Updated Guidelines on the Management of Cytomegalovirus Reactivation in Patients with Chronic Lymphocytic Leukemia Treated with Alemtuzumab

✍ Scribed by O'Brien, Susan M.; Keating, Michael J.; Mocarski, Edward S.

Book ID: 119935913
Publisher: CIG Media Group, LP.
Year: 2006
Tongue: English
Weight: 140 KB
Volume: 7
Category: Article
ISSN: 1557-9190
DOI: 10.3816/clm.2006.n.049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of infections in patients wit

Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab

✍ Thomas Elter; Janne J. Vehreschild; John Gribben; Oliver A. Cornely; Andreas Eng 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 221 KB

Progress with Alemtuzumab in Chronic Lym

Progress with Alemtuzumab in Chronic Lymphocytic Leukemia: Update from the 2003 Meeting of the American Society of Hematology

✍ Lee, David; Jain, Vinay K. 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 94 KB

Successful alemtuzumab retreatment in pr

Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients

✍ Michael Fiegl; Florian Falkner; Michael Steurer; Niklas Zojer; Georg Hopfinger; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 240 KB

Alemtuzumab by continuous intravenous in

Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence

✍ Stefan Faderl; Alessandra Ferrajoli; William Wierda; Susan O'Brien; Susan Lerner 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

Erratum: Alemtuzumab by continuous intra

Erratum: Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence

✍ Stefan Faderl; Alessandra Ferrajoli; William Wierda; Susan O'Brien; Susan Lerner 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 2 views

Routine clinical use of alemtuzumab in p

Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia : A nation-wide retrospective study in Austria

✍ Michael Fiegl; Andreas Falkner; Georg Hopfinger; Stefan Brugger; August Zabernig 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB 👁 1 views

## Abstract ## BACKGROUND. In previous studies, alemtuzumab demonstrated considerable activity in patients with previously treated B‐cell chronic lymphocytic leukemia (CLL), including fludarabine‐refractory disease. In this retrospective study, the authors evaluated the benefit of alemtuzumab mono